RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells
Tóm tắt
Từ khóa
Tài liệu tham khảo
Audeh, 2010, Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial, Lancet, 376, 245, 10.1016/S0140-6736(10)60893-8
Balbous, 2014, A mesenchymal glioma stem cell profile is related to clinical outcome, Oncogenesis, 3, e91, 10.1038/oncsis.2014.5
Bao, 2006, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, 444, 756, 10.1038/nature05236
Berezovsky, 2014, Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation, Neoplasia, 16, 193, 10.1016/j.neo.2014.03.006
Budke, 2012, RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells, Nucleic Acids Res., 40, 7347, 10.1093/nar/gks353
Budke, 2012, An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity, J. Med. Chem., 56, 254, 10.1021/jm301565b
Burchill, 1994, Neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction (RT-PCR) for tyrosine hydroxylase mRNA, Int. J. Cancer, 57, 671, 10.1002/ijc.2910570510
Callen, 2013, 53BP1 mediates productive and mutagenic DNA repair through distinct phosphoprotein interactions, Cell, 153, 1266, 10.1016/j.cell.2013.05.023
Caren, 2015, Glioblastoma stem cells respond to differentiation cues but fail to undergo commitment and terminal cell-cycle arrest, Stem Cell Rep., 5, 829, 10.1016/j.stemcr.2015.09.014
Chapman, 2012, BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair, J. Cell. Sci., 125, 3529, 10.1242/jcs.105353
Chapman, 2013, RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection, Mol. Cell, 49, 858, 10.1016/j.molcel.2013.01.002
Cheng, 2011, L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1, EMBO J., 30, 800, 10.1038/emboj.2011.10
Demidenko, 2010, Three endpoints of in vivo tumour radiobiology and their statistical estimation, Int. J. Radiat. Biol., 86, 164, 10.3109/09553000903419304
Dirks, 2008, Brain tumor stem cells: bringing order to the chaos of brain cancer, J. Clin. Oncol., 26, 2916, 10.1200/JCO.2008.17.6792
Dong, 2015, p53 suppresses hyper-recombination by modulating BRCA1 function, DNA Repair, 33, 60, 10.1016/j.dnarep.2015.06.005
Douglas, 1976, The effect of multiple small doses of X rays on skin reactions in the mouse and a basic interpretation, Radiat. Res., 66, 401, 10.2307/3574407
Facchino, 2010, BMI1 confers radioresistance to normal and cancerous neural stem cells through recruitment of the DNA damage response machinery, J. Neurosci., 30, 10096, 10.1523/JNEUROSCI.1634-10.2010
Hall, 2006
Hannay, 2007, RAD51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation, Mol. Cancer Ther., 6, 1650, 10.1158/1535-7163.MCT-06-0636
Helleday, 2011, The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings, Mol. Oncol., 5, 387, 10.1016/j.molonc.2011.07.001
Huang, 2014, A small molecule inhibitor of human RAD51 potentiates breast cancer cell killing by therapeutic agents in mouse xenografts, PLoS One, 9, e100993, 10.1371/journal.pone.0100993
Huang, 2012, Inhibition of homologous recombination in human cells by targeting RAD51 recombinase, J. Med. Chem., 55, 3011, 10.1021/jm201173g
Jeggo, 2011, The role of homologous recombination in radiation-induced double-strand break repair, Radiother. Oncol., 101, 7, 10.1016/j.radonc.2011.06.019
Johnson, 1992, Saccharomyces cerevisiae RAD5-encoded DNA repair protein contains DNA helicase and zinc-binding sequence motifs and affects the stability of simple repetitive sequences in the genome, Mol. Cell. Biol., 12, 3807, 10.1128/MCB.12.9.3807
Lee, 2006, Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines, Cancer Cell, 9, 391, 10.1016/j.ccr.2006.03.030
Lee, 2015, FoxM1 promotes stemness and radio-resistance of glioblastoma by regulating the master stem cell regulator Sox2, PLoS One, 10, e0137703, 10.1371/journal.pone.0137703
Lemke, 2014, Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?, J. Neurochem., 131, 251, 10.1111/jnc.12802
Lim, 2012, A role for homologous recombination and abnormal cell-cycle progression in radioresistance of glioma-initiating cells, Mol. Cancer Ther., 11, 1863, 10.1158/1535-7163.MCT-11-1044
Lim, 2014, Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells, Mol. Oncol., 8, 1603, 10.1016/j.molonc.2014.06.012
Maacke, 2000, DNA repair and recombination factor RAD51 is over-expressed in human pancreatic adenocarcinoma, Oncogene, 19, 2791, 10.1038/sj.onc.1203578
Mannino, 2011, Radioresistance of glioma stem cells: intrinsic characteristic or property of the “microenvironment-stem cell unit?”, Mol. Oncol., 5, 374, 10.1016/j.molonc.2011.05.001
Mehrara, 2007, Specific growth rate versus doubling time for quantitative characterization of tumor growth rate, Cancer Res., 67, 3970, 10.1158/0008-5472.CAN-06-3822
Piccirillo, 2006, Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells, Nature, 444, 761, 10.1038/nature05349
Pollard, 2009, Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens, Cell Stem Cell, 4, 568, 10.1016/j.stem.2009.03.014
Qin, 2014, Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G(2) checkpoint and suppression of homologous recombination repair, J. Hematol. Oncol., 7, 62, 10.1186/s13045-014-0062-8
Restrepo, 2011, Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomas, Neuro Oncol., 13, 42, 10.1093/neuonc/noq145
Schindelin, 2012, Fiji: an open-source platform for biological-image analysis, Nat. Methods, 9, 676, 10.1038/nmeth.2019
Short, 2011, RAD51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells, Neuro Oncol., 13, 487, 10.1093/neuonc/nor010
Suva, 2014, Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells, Cell, 157, 580, 10.1016/j.cell.2014.02.030
Tennstedt, 2012, RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma, Int. J. Cancer, 132, 2118, 10.1002/ijc.27907
Tutt, 2010, The future is “PARP” – phase-II-activity of PARP inhibitor among patients with BRCA-deficient breast cancer, Breast Care, 5, 364
Ward, 2015, Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51, Cancer Treat. Rev., 41, 35, 10.1016/j.ctrv.2014.10.006
Welsh, 2009, RAD51 protein expression and survival in patients with glioblastoma multiforme, Int. J. Radiat. Oncol. Biol. Phys., 74, 1251, 10.1016/j.ijrobp.2009.03.018
Wright, 2015, RandomSpot: a web-based tool for systematic random sampling of virtual slides, J. Pathol. Inform., 6, 8, 10.4103/2153-3539.151906
Wurdak, 2010, An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation, Cell Stem Cell, 6, 37, 10.1016/j.stem.2009.11.002
Xie, 2007, Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair, Mol. Cell, 28, 1045, 10.1016/j.molcel.2007.12.005
Yamamoto, 1996, Cell cycle-dependent expression of the mouse RAD51 gene in proliferating cells, Mol. Gen. Genet., 251, 1
Zeppernick, 2008, Stem cell marker CD133 affects clinical outcome in glioma patients, Clin. Cancer Res., 14, 123, 10.1158/1078-0432.CCR-07-0932